Yossef Av-Gay Selected Research

1- inosityl- 2- acetamido- 2- deoxyglucopyranoside

6/2006

Purification and characterization of Mycobacterium tuberculosis 1D-myo-inosityl-2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase, MshB, a mycothiol biosynthetic enzyme.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yossef Av-Gay Research Topics

Disease

19	Tuberculosis (Tuberculoses) 01/2022 - 05/2002
15	Infections 01/2022 - 10/2003
2	Persistent Infection 01/2017 - 08/2005
2	Bacterial Infections (Bacterial Infection) 08/2011 - 10/2007
1	COVID-19 01/2021
1	Acute-Phase Reaction 01/2019
1	Bronchiolitis 01/2018
1	Human Influenza (Influenza) 05/2013
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2013
1	Communicable Diseases (Infectious Diseases) 07/2012
1	Bacteriuria 08/2011
1	Cross Infection (Nosocomial Infection) 01/2010
1	Urinary Tract Infections (Urinary Tract Infection) 01/2010
1	Healthcare-Associated Pneumonia 02/2009
1	Methemoglobinemia 02/2009
1	Wounds and Injuries (Trauma) 02/2009
1	Cystic Fibrosis (Mucoviscidosis) 02/2009
1	Paratuberculosis (Johne's Disease) 12/2006

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 01/2022 - 05/2004
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 02/2009
4	Proteins (Proteins, Gene)FDA Link 10/2014 - 05/2002
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2017 - 08/2005
2	VaccinesIBA 01/2021 - 10/2007
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2017 - 12/2006
2	Protein Tyrosine PhosphatasesIBA 01/2015 - 06/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2013 - 12/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2011 - 02/2009
2	EnzymesIBA 06/2010 - 06/2006
2	Peptides (Polypeptides)IBA 10/2007 - 09/2006
1	AntigensIBA 01/2021
1	4-N,N-dimethylamino-1,8-naphthalimideIBA 02/2020
1	Coloring Agents (Dyes)IBA 02/2020
1	TrehaloseIBA 02/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2018
1	N(1)- pentadecanoyl- N(3'')- trifluoracetylkanamycin AIBA 11/2017
1	Amino Acids FDA Link 10/2014
1	Antiviral Agents (Antivirals)IBA 05/2013
1	LipidsIBA 04/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2013
1	Vasodilator Agents (Vasodilators)IBA 07/2012
1	Therapeutic UsesIBA 07/2012
1	nitazoxanide (NTZ)FDA Link 01/2012
1	Adenosine Triphosphatases (ATPase)IBA 11/2011
1	Drug CombinationsIBA 08/2011
1	TitaniumIBA 10/2010
1	SilverIBA 10/2010
1	ThioredoxinsIBA 10/2009
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 10/2009
1	mycothiolIBA 10/2009
1	Thioredoxin-Disulfide ReductaseIBA 10/2009
1	Anti-Infective Agents (Microbicides)IBA 02/2009
1	Histocompatibility Antigens Class IIIBA 10/2007
1	Tuberculosis VaccinesIBA 10/2007
1	invariant chain (Ii-Key)IBA 10/2007
1	cathepsin SIBA 10/2007
1	Tyrosine (L-Tyrosine)FDA Link 12/2006
1	mycothiol S-conjugate amidaseIBA 06/2006
1	1- inosityl- 2- acetamido- 2- deoxyglucopyranosideIBA 06/2006
1	Interleukin-10 (Interleukin 10)IBA 10/2005
1	Ethambutol (Myambutol)FDA LinkGeneric 05/2004
1	adducinIBA 10/2003
1	Protein Kinase C-epsilonIBA 10/2003
1	Phospho-Specific AntibodiesIBA 10/2003
1	lipoarabinomannan (LAM)IBA 10/2003
1	Protein Kinases (Protein Kinase)IBA 10/2003
1	Glycogen Synthase KinasesIBA 10/2003
1	DiamideIBA 03/2003

Therapy/Procedure

3	Therapeutics 01/2022 - 08/2011
3	Catheters 01/2017 - 01/2010
1	Immunomodulation 01/2021
1	Urinary Catheters 08/2011